2007/507/EC: Commission Decision of 16 July 2007 amending Decision 2006/140/EC as regards a financial contribution by the Community for the year 2007 relating to the survey on TSE resistant PrP genes in goats in Cyprus (notified under document number C(2007) 3369)
Date: 2007-07-16
Institutions: European Commission
Subjects: Cyprus, EU financing, animal disease, goat, medical research, veterinary medicine

L 186/46

EN

Official Journal of the European Union

18.7.2007

COMMISSION DECISION

of 16 July 2007

amending Decision 2006/140/EC as regards a financial contribution by the Community for the year
2007 relating to the survey on TSE resistant PrP genes in goats in Cyprus

(notified under document number C(2007) 3369)

(Only the Greek text is authentic)

(2007/507/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

to be financed from the European Agricultural Guarantee
Fund. For financial control purposes, Articles 9, 36 and
37 of that Regulation are to apply.

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), and in particular,
Article 20 thereof,

Whereas:

(1)

(2)

Eradication of transmissible spongiform encephalopathies
(TSEs) in small ruminants, including bovine spongiform
encephalopathy (BSE) which is considered to be the cause
of the fatal variant Creutzfeld Jacob disease in humans, is
of major importance for animal health and consumer’s
protection.

A bi-annual survey on TSEs resistant genotypes in goats
was submitted by Cyprus in 2005, with a view to obtain
financial support from the Community. The objectives of
that survey are to further investigate the PrP gene of
goats in that Member State in order to confirm the
results of previous preliminary studies where specific
PrP polymorphisms were found indicating resistance
against TSEs and to evaluate the data in order to be
able
the baseline prevalence of TSE
resistant PrP genes in goats. Cyprus has a very high
prevalence of TSEs in goats and is therefore the appro-
priate Member State to carry out such pilot project. The
survey started on 1 January 2006.

to determine

(3)

In accordance with Article 3(2)(a) of Council Regulation
(EC) No 1290/2005 (2) of 21 June 2005 on the financing
of the common agricultural policy, animal disease eradi-
cation and control programmes (veterinary measures) are

(1) OJ L 224, 18.8.1990, p. 19. Decision last amended by Regulation

(EC) No 1791/2006 (OJ L 363, 20.12.2006, p. 1).

(2) OJ L 209, 11.8.2005, p. 1. Regulation last amended by Regulation

(EC) No 378/2007 (OJ L 95, 5.4.2007, p. 1).

(4)

(5)

(6)

(7)

(8)

(9)

Commission Decision 2006/140/EC of 15 February
2006 concerning a specific financial contribution from
the Community relating to the survey on TSE resistant
PrP genes in goats presented by Cyprus for the year
2006 (3) granted a financial contribution from the
Community for the year 2006 for the study of genetic
resistance to TSE in goats in that Member State.

For budgetary reasons, Community assistance is decided
each year. It is appropriate to grant a financial contri-
bution from the Community for that survey to cover the
year 2007. Decision 2006/140/EC should therefore be
amended to cover that year.

The Annex to Decision 2006/140/EC lists the financial
the Community and also the means of
assistance of
technical and financial reporting. That annex should be
amended to take account of financial assistance for the
year 2007 and also changes in reporting for that year.

a

for

financial

contribution

For reasons of administrative efficiency all expenditure
presented
the
Community should be expressed in euro. In accordance
with Council Regulation (EC) No 1290/2005,
the
conversion rate for expenditure in a currency other
than euro should be the rate most recently set by the
European Central Bank prior to the first day of
the
month in which the application is submitted by Cyprus.

by

Decision 2006/140/EC should therefore be amended
accordingly.

The measures provided for
accordance with
Committee on the Food Chain and Animal Health,

in this Decision are in
Standing
the

opinion

the

of

(3) OJ L 54, 24.2.2006, p. 44.

18.7.2007

EN

Official Journal of the European Union

L 186/47

HAS ADOPTED THIS DECISION:

Article 1

Decision 2006/140/EC is amended as follows:

1. Article 1 is replaced by the following:

‘Article 1

1.
The survey programme for TSE resistant PrP genes in
goats presented by Cyprus is hereby approved for a period of
24 months starting from 1 January 2006.

2.
The financial assistance from the Community for the
programme referred to in paragraph 1 covers the costs (VAT
excluded) incurred by Cyprus for laboratory testing up to
100 % in accordance with Chapter 1 of the Annex for the
year 2006 and Chapter 3 for the year 2007. The total
assistance shall be a maximum amount of EUR 47 500 for
the year 2006 and EUR 103 000 for the year 2007.’

2. Article 2 is amended as follows:

(a) points (b) and (c) are replaced by the following:

‘(b)

(c)

forwarding an intermediate yearly financial and
technical evaluation covering the first eight months
of each year of the survey, at the latest two months
after the end of that period; the report shall conform
to the model as set out in Chapter 2 of the Annex
for the year 2006 and Chapter 4 thereof for the year
2007, accompanied by justifying evidence as to the
costs incurred.

forwarding a final yearly report for each year of the
survey by 31 March 2007 at the latest for the year
2006 and 31 March 2008 at the latest for the year
2007, on the overall execution and results of the
during which
survey
the
Community financial assistance was granted;
and financial
report
evaluation covering the years 2006 and 2007,
in
accordance with the model as set out in Chapter 2

the whole

contain a

technical

period

shall

for

of the Annex for the year 2006 and Chapter 4
thereof for the year 2007, accompanied by justifying
evidence as to the costs incurred.’

(b) paragraph 2 is replaced by the following:

‘2. When the time limit provided for in paragraph 1c)
are not respected,
the financial contribution shall be
reduced by 25 % on 1 May, 50 % on 1 June, 75 % on
1 July and 100 % on 1 September of the calendar year
following the survey year concerned.’

3. Article 3 is replaced by the following:

‘Article 3

The expenditure presented by Cyprus for a financial contri-
bution by the Community shall be expressed in euro and
shall exclude value added tax and other taxes.

The conversion rate for expenditure shall be the rate most
recently set by the European Central Bank prior to the first
day of the month in which the application is submitted by
Cyprus.’

4. The Annex is amended in accordance with the Annex to this

Decision.

Article 2

This Decision shall apply from 1 January 2007.

Article 3

This Decision is addressed to the Republic of Cyprus.

Done at Brussels, 16 July 2007.

For the Commission

Markos KYPRIANOU
Member of the Commission

L 186/48

EN

Official Journal of the European Union

18.7.2007

ANNEX

The following Chapters 3 and 4 are added to Annex to Decision 2006/140/EC:

‘CHAPTER 3

Financial assistance of the Community

Costs

Number of units

Unitary cost in
Euro

Total cost in
Euro

Community assistance

PrP genotyping
SNP analysis/DNA sequencing

11 000 analyses

EUR 8

EUR 88 000

Rapid testing:
consumables

test kits and

1 500 tests

EUR 10

EUR 15 000

Costs of maximum 88 000
analyses at maximum EUR 8
per analysis

Costs of maximum 1 500 tests
at maximum EUR 10 per test

Total:

Maximum EUR 103 000

CHAPTER 4

Technical and financial reporting

Section A: Technical report

Reporting period from . . . . . . . . . . . . . . . . . . . . . . . .

to . . . . . . . . . . . . . . . . . . . . . . . .

Determination of PrP genotype by SNP analysis/DNA sequencing

Number of samples with amino acids at codon 146:

Aspartic acid

Serine

…

Other

Breed survey: Damascus

Breed survey: Saanen

Breed survey: Macheras Local

Breed survey: Local

Breed survey: French Alpine

Scrapie-free herds (nuclei units)

Histologically TSE + suspects, rapid test +

Section B: Statement on costs incurred for control (1)

Reporting period from . . . . . . . . . . . . . . . . . . . . . . . .

to . . . . . . . . . . . . . . . . . . . . . . . .

Reference number of Commission Decision providing financial assistance:

. . . . . . . . . . . . . . . . . . . . . . . .

Costs incurred related to

Number of units

Costs incurred during the reporting period
(national currency)

PrP genotyping by SNP analysis/DNA sequencing.
Number of tests:

Rapid testing. Number of tests

(1) When presenting the final report referred to in Article 2(c), for each item a listing of all expenditures shall be provided together with a

copy of supporting documents.’